|
Gene: ITFG1 |
Gene summary for ITFG1 |
Gene summary. |
Gene information | Species | Human | Gene symbol | ITFG1 | Gene ID | 81533 |
Gene name | integrin alpha FG-GAP repeat containing 1 | |
Gene Alias | 2310047C21Rik | |
Cytomap | 16q12.1 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | B4DXC2 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
81533 | ITFG1 | CCI_1 | Human | Cervix | CC | 2.44e-08 | 1.10e+00 | 0.528 |
81533 | ITFG1 | CCI_2 | Human | Cervix | CC | 8.26e-05 | 8.57e-01 | 0.5249 |
81533 | ITFG1 | CCI_3 | Human | Cervix | CC | 1.28e-07 | 1.03e+00 | 0.516 |
81533 | ITFG1 | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.66e-26 | -7.28e-01 | 0.0155 |
81533 | ITFG1 | HTA11_2487_2000001011 | Human | Colorectum | SER | 5.45e-04 | -4.29e-01 | -0.1808 |
81533 | ITFG1 | HTA11_2951_2000001011 | Human | Colorectum | AD | 1.94e-02 | -6.25e-01 | 0.0216 |
81533 | ITFG1 | HTA11_3361_2000001011 | Human | Colorectum | AD | 1.28e-13 | -6.11e-01 | -0.1207 |
81533 | ITFG1 | HTA11_696_2000001011 | Human | Colorectum | AD | 1.80e-07 | -2.83e-01 | -0.1464 |
81533 | ITFG1 | HTA11_5212_2000001011 | Human | Colorectum | AD | 1.20e-02 | -4.71e-01 | -0.2061 |
81533 | ITFG1 | HTA11_9341_2000001011 | Human | Colorectum | SER | 1.06e-04 | -8.08e-01 | -0.00410000000000005 |
81533 | ITFG1 | HTA11_7862_2000001011 | Human | Colorectum | AD | 4.30e-05 | -4.19e-01 | -0.0179 |
81533 | ITFG1 | HTA11_866_3004761011 | Human | Colorectum | AD | 3.11e-21 | -6.12e-01 | 0.096 |
81533 | ITFG1 | HTA11_8622_2000001021 | Human | Colorectum | SER | 1.57e-05 | -7.74e-01 | 0.0528 |
81533 | ITFG1 | HTA11_10711_2000001011 | Human | Colorectum | AD | 1.07e-07 | -5.44e-01 | 0.0338 |
81533 | ITFG1 | HTA11_7696_3000711011 | Human | Colorectum | AD | 1.13e-08 | -4.67e-01 | 0.0674 |
81533 | ITFG1 | HTA11_6818_2000001011 | Human | Colorectum | AD | 4.33e-02 | -4.24e-01 | 0.0112 |
81533 | ITFG1 | HTA11_6818_2000001021 | Human | Colorectum | AD | 9.18e-04 | -5.09e-01 | 0.0588 |
81533 | ITFG1 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 4.62e-16 | -5.06e-01 | 0.294 |
81533 | ITFG1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.20e-03 | -3.39e-01 | 0.3859 |
81533 | ITFG1 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 7.29e-06 | -5.33e-01 | 0.2585 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ITFG1 | SNV | Missense_Mutation | rs747170277 | c.1130C>T | p.Ala377Val | p.A377V | Q8TB96 | protein_coding | tolerated(0.69) | benign(0) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ITFG1 | SNV | Missense_Mutation | c.691N>G | p.Thr231Ala | p.T231A | Q8TB96 | protein_coding | tolerated(0.59) | benign(0) | TCGA-AX-A063-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ITFG1 | SNV | Missense_Mutation | c.626T>G | p.Phe209Cys | p.F209C | Q8TB96 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-AX-A0J0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ITFG1 | SNV | Missense_Mutation | c.372T>G | p.Asn124Lys | p.N124K | Q8TB96 | protein_coding | tolerated(0.23) | benign(0.006) | TCGA-AX-A0J0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ITFG1 | SNV | Missense_Mutation | novel | c.1345N>C | p.Cys449Arg | p.C449R | Q8TB96 | protein_coding | deleterious(0) | probably_damaging(0.988) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ITFG1 | SNV | Missense_Mutation | novel | c.1036N>A | p.Asp346Asn | p.D346N | Q8TB96 | protein_coding | deleterious(0.01) | benign(0.176) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ITFG1 | SNV | Missense_Mutation | novel | c.275C>A | p.Ser92Tyr | p.S92Y | Q8TB96 | protein_coding | tolerated(0.32) | possibly_damaging(0.461) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ITFG1 | SNV | Missense_Mutation | c.1238N>C | p.Val413Ala | p.V413A | Q8TB96 | protein_coding | deleterious(0) | benign(0.033) | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ITFG1 | SNV | Missense_Mutation | novel | c.1037N>G | p.Asp346Gly | p.D346G | Q8TB96 | protein_coding | deleterious(0) | possibly_damaging(0.559) | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ITFG1 | SNV | Missense_Mutation | novel | c.984N>G | p.Ile328Met | p.I328M | Q8TB96 | protein_coding | tolerated(0.23) | benign(0.297) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |